CRF Bracket, which was formed as a merged entity of CRF Health and Bracket, was launched as Signant Health.
Combining eCOA, patient Engagement, eConsent, clinical supplies and endpoint quality into the industry’s patient-centric suite, Signant claims to simplify the process of global drug development.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The new brand is focused on patient experience, deep therapeutic area expertise, and global operational scale.
It enables sponsors and contract research organisations (CROs) to extend the reach of drug development and expand patient opportunities in clinical trials, besides improving data quality.
Signant Health chief executive officer Mike Nolte said: “The best technology in clinical research succeeds in the background.
“We work to be expert, with proven solutions and scientific support that simplify research for patients, sponsors and CROs. I’m humbled to be a part of our customers’ important work, proud of the Signant Health team and excited to continue to innovate along every step of the patient journey.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSignant Health combines a suite of technologies with expert developers, project managers, data scientists and clinicians dedicated to help customers by introducing life-changing therapeutics.
Nolte added: “The new Signant brand reflects our desire to help separate signal from noise at the intersection of science and technology and to never forget that our customers’ significant work matters locally and globally.
“In 2018, CRF Health and Bracket brought together industry-leading technology and analytics solutions, renowned executive and scientific leaders, and 20 years of experience delivering exemplary service to life science companies worldwide. The birth of Signant Health marks the next phase in our journey and unlocks extraordinary opportunities to improve the patient’s journey as well.”
